German enteral feeding decision "is electioneering"
This article was originally published in Clinica
Executive Summary
The honorary chairman of the statutory health insurance physicians of the German federal state of Hesse, Dr Jurgen Bausch, last week accused the federal ministry of health of delaying a decision on enteral feeding (see Clinica No 1009, p 5) in order to win time ahead of the forthcoming general election September. He said that the ministry had known about the decision of the federal committee of doctors and sickness funds to remove enteral feeding from the catalogue of reimbursable procedures since 1999, when it was presented with draft proposals for amendments to the pharmaceutical guidelines. "But two months after the committee's decision of June 2, it suddenly occurred to the ministry that a health technology assessment (HTA) report would be needed in order to be sure of the move," said Dr Bausch.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.